Literature DB >> 12380918

Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction.

Eric J Rashba1, Ahmed F Osman, Karen MacMurdy, Malcolm M Kirk, Samantha Sarang, Robert W Peters, Stephen R Shorofsky, Michael R Gold.   

Abstract

INTRODUCTION: T wave alternans (TWA) is a heart rate-dependent marker of vulnerability to ventricular arrhythmias. Atrial pacing and exercise both are used as provocative stimuli to elicit TWA. However, the prognostic value of the two testing methods has not been compared. The aim of this prospective study was to compare the prognostic value of TWA measured during bicycle exercise and atrial pacing in a large cohort of high-risk patients with ischemic heart disease and left ventricular dysfunction. METHODS AND
RESULTS: This was a prospective study of 251 patients with coronary artery disease and left ventricular dysfunction who were referred for electrophysiologic studies (EPS) for standard clinical indications. Patients underwent TWA testing using bicycle ergometry (exercise TWA, n = 144) and/or atrial pacing (pacing TWA, n = 178). The primary endpoint was the combined incidence of death, sustained ventricular arrhythmias, and appropriate implantable cardioverter defibrillator therapy. The predictive value of exercise and pacing TWA for EPS results and for endpoint events was determined. Exercise and pacing TWA both were significant predictors of EPS results (odds ratios 3.0 and 2.9 respectively, P < 0.02). Kaplan-Meier survival analysis of the primary endpoint revealed that exercise TWA was a significant predictor of events (hazard ratio 2.2, P = 0.03). In contrast, pacing TWA had no prognostic value for endpoint events (hazard ratio 1.1, P = 0.8).
CONCLUSION: TWA should be measured during exercise when it is used for clinical risk stratification. EPS results may not be an adequate surrogate for spontaneous events when evaluating new risk stratification tests.

Entities:  

Mesh:

Year:  2002        PMID: 12380918     DOI: 10.1046/j.1540-8167.2002.00845.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  14 in total

1.  Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators?

Authors:  K Kraaier; T McCracken; J van der Palen; A A M Wilde; M F Scholten
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

2.  Is T-wave alternans as good or better than programmed ventricular stimulation?

Authors:  Sanjiv M Narayan
Journal:  Heart Rhythm       Date:  2007-03-23       Impact factor: 6.343

Review 3.  T-wave alternans: reviewing the clinical performance, understanding limitations, characterizing methodologies.

Authors:  Euler de Vilhena Garcia
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

Review 4.  T-wave alternans testing for ventricular arrhythmias.

Authors:  Sanjiv M Narayan
Journal:  Prog Cardiovasc Dis       Date:  2008 Sep-Oct       Impact factor: 8.194

5.  Assessment of physiological amplitude, duration, and magnitude of ECG T-wave alternans.

Authors:  Laura Burattini; Wojciech Zareba; Roberto Burattini
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

6.  Dependency of exercise-induced T-wave alternans predictive power for the occurrence of ventricular arrhythmias from heart rate.

Authors:  Laura Burattini; Sumche Man; Sandro Fioretti; Francesco Di Nardo; Cees A Swenne
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 7.  Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.

Authors:  Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum
Journal:  J Am Coll Cardiol       Date:  2011-09-20       Impact factor: 24.094

8.  Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.

Authors:  Bruce D Nearing; Gregory A Wellenius; Murray A Mittleman; Mark E Josephson; Andrew J Burger; Richard L Verrier
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-12-08

9.  Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.

Authors:  Michael R Gold; John H Ip; Otto Costantini; Jeanne E Poole; Steven McNulty; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

Review 10.  T-wave alternans for risk stratification and prevention of sudden cardiac death.

Authors:  Etienne J Pruvot; David S Rosenbaum
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.